Multiple Sclerosis Clinical Trial
LEMTRADA Pregnancy Registry in Multiple Sclerosis
Summary
Primary Objective:
The primary goal of this registry is to assess the risk of spontaneous abortion in prospective enrolled women exposed to LEMTRADA for multiple sclerosis.
Secondary Objective:
The secondary goals of this registry is to assess maternal, fetal and infant outcome in women with multiple sclerosis, exposed to LEMTRADA.
Full Description
From enrollment during pregnancy up to 1 year after delivery for infant follow-up (maximum approximatively 20 months)
Eligibility Criteria
Inclusion criteria :
Women with Multiple Sclerosis who were or became pregnant within the period of time between the first infusion of a course of treatment with LEMTRADA to 4 months after their last infusion for that course.
Women able and willing to provide informed consent for study participation and the requirement of the study. Informed consent will be obtained at the time of enrollment in accordance with local regulatory requirements.
Exclusion criteria:
- Previous enrollment in this study for a previous pregnancy.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 9 Locations for this study
New York New York, 00000, United States
Box Hill Victoria, 3128, Australia
Linz , , Austria
Charleroi , 6000, Belgium
Canada , , Canada
Aarhus C , 8000, Denmark
Bochum , 44791, Germany
Gallarate (VA) , 21013, Italy
Netherlands , , Netherlands
Spain , , Spain
Göteborg , 41345, Sweden
Zürich , 8091, Switzerland
Salford , M6 8H, United Kingdom
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.